managing-controlled-substances
Managing Controlled Substances
Tracks controlled substance prescribing with PDMP review, risk assessment, and compliance monitoring across all DEA schedules.
Why This Skill Exists
The United States continues to face an opioid crisis that has killed over 600,000 people since 1999. The DEA Controlled Substances Act (CSA) classifies drugs into Schedules I-V based on abuse potential and accepted medical use. Federal and state regulations impose strict requirements on prescribing, dispensing, inventory management, and destruction of controlled substances. Non-compliance carries criminal penalties, DEA license revocation, and institutional liability.
State Prescription Drug Monitoring Programs (PDMPs) are now mandatory in 49 states, and most require pharmacist review before dispensing opioids and benzodiazepines. The CDC Clinical Practice Guideline for Prescribing Opioids (2022 revision) recommends non-opioid first-line therapy, lowest effective dose, and defined treatment durations. Pharmacists are legally responsible for corresponding responsibility—ensuring that every controlled substance prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. Pharmacists must refuse to fill prescriptions that fail this standard, even if technically valid on paper.